Table 1.
Background characteristics of study patients with and without hepatocellular carcinoma (HCC) (n = 76)
| Patients with HCC (n = 20) | Patients without HCC (n = 56) | P‐value | |
|---|---|---|---|
| Mean age ± SD, years (range) | 72.4 ± 8.0 (46–83) | 70.0 ± 9.8 (46–86) | 0.3211 |
| Sex, female/male | 6 (30.0)/14 (70.0) | 19 (33.9)/37 (66.1) | 0.9651 |
| Albumin, g/dL (mean ± SD) | 3.82 ± 0.42 | 3.97 ± 0.51 | 0.2276 |
| Total bilirubin, mg/dL (mean ± SD) | 1.02 ± 0.65 | 0.82 ± 0.52 | 0.1288 |
| Platelets (×103/μL) | 158 ± 75 | 160 ± 49 | 0.4754 |
| INR | 1.75 ± 0.58 | 1.76 ± 0.58 | 0.7816 |
| Mean tumor size ± SD, cm (range) | 3.35 ± 1.84 (1.1–8.4) | – | – |
| Number of tumors, single/multiple | 15 (75.0)/5 (25.0) | – | – |
| Tumor stage, I/II/IIIa | 3 (15.0)/11 (55.0)/6 (30.0) | – | – |
a
According to the TNM classification of the Liver Cancer Study Group of Japan. Unless otherwise indicated, values in parentheses indicate percentages. INR, International normalized ratio.